PLPL 0.00 Plandaí Biotechnology, Inc.
| Range: | 1.0E-4-7.0E-4 | Vol Avg: | 43033843 | Last Div: | 0 | Changes: | 0 |
| Beta: | -1.83 | Cap: | 0.00B | Currency: | USD | Exchange: | PNK |
| Sector: | Financial Services | IPO: | Thu Feb 02 1995 | Empoloyees: | 180 | ||
| CUSIP: | CIK: | 0001317880 | ISIN: | US72703D1000 | Country: | GB | |
| CEO: | Mr. Roger Baylis-Duffield | Website: | https://www.plandaibiotech.com | ||||
Plandaí Biotechnology, Inc. focuses on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries. It is developing Phytofare Catechin Complex, a botanical extract derived from green tea harvested in the Senteeko Tea Estate in Mpumalanga, South Africa; and Phytofare citrus complex, a citrus extract, as well as extracts from tomato fruit, Artemisia, and cannabis. The company also produces and sells timber and agricultural products from its farm and tea estate holdings in South Africa. Plandaí Biotechnology, Inc. is based in London, the United Kingdom.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow